martes, 12 de julio de 2016

Read about Summer Safety, Osteoporosis and more

Office of Women's Health, FDA
July 2016

Message from the Director

During the summer months, FDA remains vigilant in our efforts to protect and promote the public’s health. We are supporting the response to Zika, educating the public about product safety and advancing important research. I encourage you to read about some of these activities highlighted in this update and to visit our website for ongoing updates and resources. 
Marsha Henderson, Assistant Commissioner for Women’s Health

Summer Safety Kit

Help your family and friends avoid common medication mistakes and other injuries with tips from the FDA, Consumer Product Safety Commission, and Centers for Disease Control and Prevention. Learn how to protect yourself from Zika by preventing mosquito bites, plan safe cookouts, and protect your children and guests in the home and at the pool.

New FDA Draft Guidance on Nonclinical Evaluation of Osteoporosis Drugs

medicine picture
This draft guidance provides recommendations to industry for designing a nonclinical development program to support approval of drugs to treat osteoporosis. This guidance also discusses the nonclinical development of biopharmaceuticals (e.g., recombinant proteins and monoclonal antibodies). Submit comments by August 15, 2016 for consideration for the final guidance.

July is Cord Blood Awareness Month

Cord blood is collected after a baby is born and after the umbilical cord is cut. Start the conversation about cord blood banking. Use these resources to learn the facts about cord blood and talk to your healthcare provider about your options.

FDA Grand Rounds

Tune in to FDA’s Grand Rounds, web cast live on Thursday, July 14 from 12-1p.m. EDT. LT James Coburn of FDA’s Center for Devices and Radiological Health will be speaking on FDA research into 3D printing of its regulated products.

Whole Body Cryotherapy (WBC): A “Cool Trend that Lacks Evidence, Poses Risks

Have you been hearing more about whole body cryotherapy (WBC)? FDA does not have evidence that WBC effectively treats diseases or conditions like Alzheimer’s, fibromyalgia, migraines, rheumatoid arthritis, multiple sclerosis, stress, anxiety or chronic pain.

FDA Meetings

July 12 - 13, 7:30 a.m. to 5:00 p.m.
FDA White Oak Campus, Silver Spring, MD
July 21 - 22, 8:00 a.m. to 6:00 p.m.
Hilton Washington DC North/Gaithersburg, Gaithersburg, MD
August 29, 9:00 a.m. to 5:00 p.m.
FDA White Oak Campus, Silver Spring, MD

OWH Conference Exhibits

National Association of Hispanic Nurses – July 12-15, Chicago, IL
LULAC (League of United Latin American Citizens) –July 12-16, Washington, DC
National Council of La Raza (NCLR) – July 23-26, Orlando, FL

No hay comentarios:

Publicar un comentario